As specialty drug costs continue to climb, self-insured health plans, TPAs, and workers’ compensation programs are feeling the financial strain. Every year, millions of dollars in manufacturer rebates go unclaimed, not because the opportunities don’t exist, but because the process is fragmented, complex, and often hidden beneath layers of contracts and data.
At VativoRx, we bridge that gap through Strategic Rebate Management, a compliant, transparent, and high-impact way to capture the rebate dollars organizations are already entitled to. Our program identifies overlooked rebate opportunities on high-cost, provider-administered medications, turning missed savings into measurable financial performance.
That’s why we’re attending the SIIA National Conference, October 12–14 in Phoenix. Our team, James Haidet and Rourke Smith, will be on-site meeting with leaders in self-insured healthcare to discuss:
- How Strategic Rebate Management offsets rising specialty drug spend
- Proven success stories from hospitals and infusion centers
- Market insights and compliance trends shaping rebate recovery in 2025
If you’re attending SIIA, let’s connect to explore how Strategic Rebate Management can help your organization reduce waste and reclaim lost value.
Ready to uncover how much your organization could be saving? Schedule a 15-minute discovery call.
